Possible roles of short-chain fatty acids in the pathophysiology and treatment of irritable bowel syndrome
World Journal of Translational Medicine · 2026
DOI: 10.5528/wjtm.122740 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Translational Medicine, 2026. Verfasst von Magdy El-Salhy und 3 weiteren Autor:innen. Die Arbeit nennt 87 Literaturangaben.
Abstract (Originalsprache)
Short-chain fatty acids (SCFAs) are metabolic products of bacterial fermentation of undigested/unabsorbed carbohydrates and fibers in the intestine. SCFAs are used by intestinal epithelial cells as an energy source and regulates several large-intestine functions, such as motility, visceral sensitivity, the immune system, and the gut barrier. About 95% of SCFAs are acetic, propionic, and butyric acids occurring in proportions of 60%: 20%: 20% in healthy subjects, while the proportion of butyric acid is lower than 20% in irritable bowel syndrome (IBS) patients. Acetic and propionic acids are not correlated with IBS symptoms, suggesting that they are not involved in symptom manifestation. The butyric acid level increased in IBS patients after fecal microbiota transplantation, and was inversely correlated with abdominal pain, diarrhea, and constipation. The effects of butyric acid on IBS symptoms such as abdominal pain, diarrhea, and constipation can be attributed to its modulation of the expression levels of serotonin, peptide YY, and glucagon-like peptide-1 in the intestinal enterochromaffin cells and L-cells. The butyric acid level was also inversely correlated with chronic fatigue, which occurs in about 54% of IBS patients. Treatment with sodium butyrate in capsule form is a promising therapeutic approach for IBS.
Zitieren
APA
El-Salhy, M., Shin, C. M., Kim, Y. S., & Hatlebakk, J. G. (2026). Possible roles of short-chain fatty acids in the pathophysiology and treatment of irritable bowel syndrome. World Journal of Translational Medicine. https://doi.org/10.5528/wjtm.122740
Vancouver
El-Salhy M, Shin CM, Kim YS, Hatlebakk JG. Possible roles of short-chain fatty acids in the pathophysiology and treatment of irritable bowel syndrome. World Journal of Translational Medicine. 2026. doi:10.5528/wjtm.122740
BibTeX
@article{ElSalhy2026,
author = {El-Salhy, Magdy and Shin, Cheol Min and Kim, Yong Sung and Hatlebakk, Jan Gunnar},
title = {Possible roles of short-chain fatty acids in the pathophysiology and treatment of irritable bowel syndrome},
journal = {World Journal of Translational Medicine},
year = {2026},
doi = {10.5528/wjtm.122740}
}
EUVIMED